Evaluation of the effects of probiotic supplementation on the ecology and inflammatory factors of female vaginal flora: a systematic review and meta-analysis
Abstract
This meta-analysis systematically evaluated the effects of probiotic supplementation on vaginal microbiota and inflammatory factors in women. PubMed, Embase, Web of Science, CNKI, and Wanfang were searched from inception to January 2026 for randomized and controlled studies. Outcomes included vaginal pH, Nugent score, and inflammatory cytokines (IL-4, IL-6, IL-10, TNF-α). Fifteen studies were included. Compared with controls, probiotics did not significantly reduce IL-4, IL-6, IL-10, or TNF-α levels, nor did they significantly improve Nugent score. However, probiotic supplementation significantly reduced vaginal pH (OR = 0.36, 95% CI: 0.15–0.89; P = 0.03), indicating improved maintenance of a weakly acidic vaginal environment. Sensitivity analyses showed generally stable results, although heterogeneity remained substantial for several outcomes. Overall, probiotics appear effective in modulating vaginal acid–base balance but show limited evidence for improving inflammatory cytokine profiles or restoring vaginal microbiota structure. Current data are insufficient to support routine probiotic use for optimizing vaginal microbiota and inflammatory status. Further high-quality, well-designed randomized controlled trials are required to clarify their clinical benefits.
Full Text:
PDFReferences
Zhu B, Tao Z, Edupuganti L, Serrano MG , Buck GA. Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health, Microbiology and Molecular Biology Reviews: MMBR, 2022;86(4):e0018121. https://doi.org/10.1128/mmbr.00181-21
Kwon MS , Lee HK. Host and Microbiome Interplay Shapes the Vaginal Microenvironment, Frontiers in Immunology, 2022;13:919728. https://doi.org/10.3389/fimmu.2022.919728
Lehtoranta L, Ala-Jaakkola R, Laitila A , Maukonen J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span, Frontiers in Microbiology, 2022;13:819958. https://doi.org/10.3389/fmicb.2022.819958
Koirala R, Gargari G, Arioli S, Taverniti V, Fiore W, Grossi E, Anelli GM, Cetin I , Guglielmetti S. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study, Fems Microbiology Ecology, 2020;96(6):fiaa084. https://doi.org/10.1093/femsec/fiaa084
Jepsen IE, Saxtorph MH, Englund ALM, Petersen KB, Wissing MLM, Hviid TVF , Macklon N. Probiotic treatment with specific lactobacilli does not improve an unfavorable vaginal microbiota prior to fertility treatment-A randomized, double-blinded, placebo-controlled trial, Frontiers in Endocrinology, 2022;13:1057022. https://doi.org/10.3389/fendo.2022.1057022
Ang XY, Mageswaran UM, Chung YLF, Lee BK, Azhar SNA, Roslan NS, Saufian IFB, Mustaffa NS, Kalam EM, Ibrahim AF, Abdul Wahid N, Deris ZZ, Oon C, Adnan WFW, Sany S , Liong M. Probiotics Reduce Vaginal Candidiasis in Pregnant Women via Modulating Abundance of Candida and Lactobacillus in Vaginal and Cervicovaginal Regions, Microorganisms, 2022;10(2):285. https://doi.org/10.3390/microorganisms10020285
Yang S, Reid G, Challis JRG, Gloor GB, Asztalos E, Money D, Seney S , Bocking AD. Effect of Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women, Nutrients, 2020;12(2):368.https://doi.org/10.3390/nu12020368
Vaccalluzzo A, Pino A, Grimaldi RL, Caggia C, Cianci S , Randazzo CL. Lacticaseibacillus rhamnosus TOM
8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population, Journal of Applied Microbiology, 2024;135(5):lxae110. https://doi.org/10.1093/jambio/lxae110
Sgibnev A , Kremleva E. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study, European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2020;39(2):345-51. https://doi.org/10.1007/s10096-019-03731-8
Vitali B, Cruciani F, Baldassarre ME, Capursi T, Spisni E, Valerii MC, Candela M, Turroni S , Brigidi P. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion, Bmc Microbiology, 2012;12:236. https://doi.org/10.1186/1471-2180-12-236
Gille C, Böer B, Marschal M, Urschitz MS, Heinecke V, Hund V, Speidel S, Tarnow I, Mylonas I, Franz A, Engel C , Poets CF. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial, American Journal of Obstetrics and Gynecology, 2016;215(5):601-8. https://doi.org/10.1016/j.ajog.2016.06.021
Bui HT, Bui ATP, Ngo HT, Ngo XT, Nguyen HT, Nguyen AH, Tran VC, Pham TD , Nguyen ATV. Vaginal-spray Bacillus spore probiotics as a potential treatment and reducing recurrence of bacterial vaginosis: randomized, double-blind, and controlled pilot study, Communications Medicine, 2025;5(1):527. https://doi.org/10.1038/s43856-025-01236-4
van de Wijgert JHHM, Verwijs MC, Agaba SK, Bronowski C, Mwambarangwe L, Uwineza M, Lievens E, Nivoliez A, Ravel J , Darby AC. Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing, Scientific Reports, 2020;10(1):3884. https://doi.org/10.1038/s41598-020-60671-6
Hemalatha R, Mastromarino P, Ramalaxmi BA, Balakrishna NV , Sesikeran B. Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study, European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2012;31(11):3097-105. https://doi.org/10.1007/s10096-012-1671-1
Park S, Lee ES, Park ST, Jeong SY, Yun Y, Kim Y, Jeong Y, Kang C , Choi HJ. Efficacy and Safety of MED-01 Probiotics on Vaginal Health: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Nutrients, 2023;15(2):331. https://doi.org/10.3390/nu15020331
Ya W, Reifer C , Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study, American Journal of Obstetrics and Gynecology, 2010;203(2):120-1. https://doi.org/10.1016/j.ajog.2010.05.023
Zhang Y, Lyu J, Ge L, Huang L, Peng Z, Liang Y, Zhang X , Fan S. Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel-Group, Randomized, Controlled Study, Frontiers in Cellular and Infection Microbiology, 2021;11:669901. https://doi.org/10.3389/fcimb.2021.669901
De Seta F, Parazzini F, De Leo R, Banco R, Maso GP, De Santo D, Sartore A, Stabile G, Inglese S, Tonon M , Restaino S. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2014;182:136-9. https://doi.org/10.1016/j.ejogrb.2014.09.018
Zhao JY, Bai R. Therapeutic effects of clotrimazole vaginal expansion suppository combined with probiotics on puerperal mycotic vaginitis. Journal of Xinjiang Medical University 2025;48(01):71-74+81.
Wang J, Shi HY, Liu Y, Tang L, Ye T. The effect of probiotics on the colonization of vaginal group B streptococcus,serum inflammatory factors and pregnancy outcome in the third trimester of pregnancy. Chinese Journal of Difficult and Complicated Cases 2022;21(01):55-58+63.
Tidbury F, Brülhart G, Müller G, Pavicic E, Weidlinger S, Eichner G, von Wolff M , Stute P. Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study, BMC Womens Health, 2025;25(1):7. https://doi.org/10.1186/s12905-024-03513-1
Khatir K, Aghaei M, Ghorbanhosseini SS , Shafiee F. In vitro Evaluation of the Cytotoxic Effects of a Recombinant form of the Soluble Mutant IL-6 Receptor on an Ovarian Cancer Cell Line, Iranian Journal of Biotechnology, 2025;23(1):e3953. https://doi.org/10.30498/ijb.2025.467140.3953
López-Moreno A , Aguilera M. Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis, Journal of Clinical Medicine, 2021;10(7):1461. https://doi.org/10.3390/jcm10071461
Soleymani F, Rahimi HR, Farsiani H , Jalili A. Antimicrobial Activity of Chitosan Scaffold Loaded with Soluble Factors of Different Probiotic Strains Against Multidrug Resistant Pseudomonas aeruginosa, Iranian Journal of Biotechnology, 2024;22(1):e3612. https://doi.org/10.30498/ijb.2024.381455.3612.
Refbacks
- There are currently no refbacks.




